Integrated Systems-Based Pharmacotherapy IIIA1 PHAR 6474 - ISBP Track - Fall P3 Course Syllabus

Sep 17, 2026

Uploaded by Liam

School of Pharmacy Required Course Syllabus for Fall P3, Integrated Systems-Based Pharmacotherapy IIIA1 (PHAR 6474) in the ISBP track, scheduled August 24 to October 16, 2026. The syllabus outlines course description and patient care process using pathophysiology, medicinal chemistry, pharmacology, and therapeutics, plus office-hour and communication procedures. It also maps course objectives to COEPA 2022, NAPLEX 2025, and ACPE Appendix 1 2025 outcomes with assessment methods and measures, covering advanced nephrology, gastroenterology, endocrinology, cardiology, and vascular disease.

LanguageEnglish

CategoryExam

FormatPDF

Pages13

Reading Time33 min

AccessFree to download

Course Information

Integrated Systems-Based Pharmacotherapy IIIA1 (ISBP Track)

Office Hours and Communication

Course Description and Scope

Course Description

Pharmacists’ Patient Care Process

Course Objectives and Outcome Mapping

COEPA 2022, NAPLEX 2025, and ACPE Appendix 1 2025

School of Pharmacy Required Course Syllabus Fall – P3 Integrated Systems-Based Pharmacotherapy IIIA1 PHAR 6474 / ISBP Track August 24 – October 16, 2026 CABL 212 Course Coordinator Natalie Gordon, PharmD, BCACP Clinical Assistant Professor Office Phone: 915-747-8557 Email: [nnarndt@utep.edu](nnarndt@utep.edu) Office Hours: Wednesdays 10-12; and by appointment (email to schedule) Additional Course Faculty: | Name | Position | Email | Office | | --- | --- | --- | --- | | Sebastian Perez, PharmD | Clinical Assistant Professor | [sebperez@utep.edu](sebperez@utep.edu) | 315 | | Harleen Singh, PharmD, BCACP, FOSHP | Clinical Professor | [hsingh3@utep.edu](hsingh3@utep.edu) | 515 | | Scott Weston, RPh, MBA, PhD | Professor | [gsweston@utep.edu](gsweston@utep.edu) | 110K | | Sandy Salazar RPh, BCSCP | Clinical Coordinator | [sosalazarab@utep.edu](sosalazarab@utep.edu) | 706 | | Kayla Maki Ortiz, PharmD, BCIDP | Clinical Assistant Professor | [krmakiortiz@utep.edu](krmakiortiz@utep.edu) | 713 | Guest Course Lecturers: | Name | Position | Email | | --- | --- | --- | | Zain Al-Jammali, PharmD | Clinical Instructor | [zain.jamaly@gmail.com](zain.jamaly@gmail.com) | | Megan Herink, PharmD, BCPS, MBA | Clinical Associate Professor | [herink@ohsu.edu](herink@ohsu.edu) | Office Hours The course coordinator will host office hours by appointment. Appointments can be requested via email or MS Teams. In general, you are welcome to drop by anytime my office door is open, however, appointments will take priority. All appointments must be made at least 6 hours in advance. Additional course faculty will notify students of their preferred contact method and available office hours at the start of their scheduled teaching. Please contact the designated faculty member regarding any questions about their content and contact them directly via email to meet with them. Course Description The Integrated Systems-Based Pharmacotherapy (ISBP) course series begins in the P2 year (primary care focus) and continues through the P3 year (advanced pharmacotherapy/acute care/specialty focus), providing the essentials for integrating foundational knowledge with practice and care. Faculty from Pharmaceutical Sciences and Clinical Sciences will work together to design a comprehensive, integrated approach to pharmacotherapy, which includes a practical application lab and an integrated lab. The topics in this course include: advanced nephrology, gastroenterology, endocrinology, cardiology, and vascular disease. Pharmacists’ Patient Care Process: This course will help students utilize the concepts of pathophysiology, medicinal chemistry, pharmacology, and therapeuticsin the evaluation and treatment of various disease states. Course Objectives mapped to National Pharmacy Education Outcomes At the conclusion of this course, students shall be expected to: | Course Obectives | COEPA 2022 | NAPLEX 2025 | ACPE Appendix 1 2025 | Level of Assessment | Outcome Measures | | --- | --- | --- | --- | --- | --- | | Objective 1: Apply the basic anatomy and physiology concepts to understand the cellular and molecular organization of the system | 1. 1, 2.1 | 3C1 | Human Anatomy,
Pathophysiology Medical Microbiology | R, A | Exams, Quizzes, Case Activities | | Objective 2: Describe the pathophysiology responsible for all disease states covered. | 1.1 | 3C1 | Pathophysiology | R | | | Objective 3: Identify structure-activity relationships (SARs) with regard to characteristic pharmacophores and drug-receptor/target interactions for specific drugs and drug classes. | 1.1 | 1A (1A1, 1A2) | Biochemistry Medicinal Chemistry | R | | | Objective 4: Describe the mechanism of pharmacologic action of specific drugs and drug classes, including toxicology, adverse effects, and drug-drug interactions (medication level). | 1.1 | 1A1,
1A2,
3C2, 3C3,
3C5, 3C6 | Biochemistry Medicinal Chemistry Pharmacology | R, A | | | Objective 5: Apply the general pr

FAQs

What is the course timeline for Integrated Systems-Based Pharmacotherapy IIIA1 (PHAR 6474)?

The course runs from August 24 to October 16, 2026, in the Fall term for P3.

Which clinical topics are included in this ISBP IIIA1 course?

Topics include advanced nephrology, gastroenterology, endocrinology, cardiology, and vascular disease.

How do course objectives align with pharmacy education outcomes?

Objectives are mapped to COEPA 2022, NAPLEX 2025, and ACPE Appendix 1 2025, with specified levels of assessment and outcome measures such as exams, quizzes, and case activities.

Sep 17, 2026

Uploaded by Liam